Orphan Drugs- Development Trends and Strategies

An orphan drug can be determined as one that is used to handle an orphan disease. For example, haem arginate, used to control small cintermittent porphyria, variegate porphyria, and hereditary coproporphyria is an orphan drug. A medicinal product which is came into the source as orphan drug is one that has been developed especially to treat a rare medical condition which is found, the condition itself being referred to as “orphan disease.” It may be defined as drugs that are not evolved by the pharmaceutical industry for economic reasons but which respond to public.

  • Acute intermittent porphyria
  • Variegate porphyria

Related Conference of Orphan Drugs- Development Trends and Strategies

February 04-05, 2026

18th International Conference on Gynecology

Rome, Italy
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 24-25, 2026

9th Global Congress on Spine and Spinal Disorders

Paris, France
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
April 27-28, 2026

40th International Conference on Psychiatry and Mental Health

Amsterdam, Netherlands
April 27-28, 2026

37th World Congress on Neurorehabilitation

Dubai, UAE
May 25-26, 2026

18th International Conference on Clinical Chemistry

Zurich, Switzerland
September 14-15, 2026

6th World Medicine Congress

Rome, Italy
November 24-25, 2026

6th International Conference on Medical Research and Development

Amsterdam, Netherlands
November 25-26, 2026

22nd World Summit on Blockchain Technology

Amsterdam, Netherlands

Orphan Drugs- Development Trends and Strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in